Spironolactone
Aldactone, Spirobene, Spirohexal, Spirono · ATC code C03DA01
Also known as: Spironolacton, Spironolakton, Spironolattone, Espironolactona, Aldactone · Brand names: Spirobeta, Spirobene, Spirohexal, Spirono, Spironolacton Agepha, Spironolacton Orion, Spironolactone Orion, Dalylacton, Ridakton, Spylacton
- Key facts
- Active substance
- Spironolactone
- Drug class
- Antimineralocorticoid
- ATC code
- C03DA01
- Authorisation
- authorised nationally; no central EU authorisation
- Information as of
- 2026-10-27
Key facts
Spironolactone is an aldosterone antagonist and potassium-sparing diuretic. Per the US label it is used for heart failure, hypertension, oedema in cirrhosis or nephrotic syndrome, and primary hyperaldosteronism.
What it is used for
- NYHA Class III–IV heart failure with reduced ejection fraction, to increase survival and reduce hospitalisation
- Add-on therapy for hypertension not adequately controlled on other agents
- Oedema in hepatic cirrhosis or nephrotic syndrome when other measures are inadequate
- Primary hyperaldosteronism (preoperative or long-term maintenance)
Dosing
- Heart failure (potassium ≤5.0 mEq/L, eGFR >50): start 25 mg once daily, may increase to 50 mg; with hyperkalaemia reduce to 25 mg every other day
- Heart failure with eGFR 30 to 50: consider starting at 25 mg every other day
- Hypertension: initial dose 25 to 100 mg daily, titrated at two-week intervals
- Oedema: usually 100 mg daily (range 25 to 200 mg); in cirrhosis start in hospital
- Take consistently with respect to food
Contraindications
- Hyperkalaemia
- Addison's disease
- Concomitant use of eplerenone
Important warnings
- Hyperkalaemia, especially with impaired renal function or potassium supplements, ACE inhibitors or ARBs; monitor potassium within 1 week of starting and regularly
- Hypotension and worsening renal function from excessive diuresis
- Electrolyte and metabolic abnormalities
- Gynaecomastia, dose-dependent and usually reversible
- In cirrhosis with ascites, risk of impaired neurological function or coma
Side effects
- Hyperkalaemia, gynaecomastia, hypotension
- Digestive: gastric bleeding, ulceration, gastritis, diarrhoea, nausea, vomiting
- Decreased libido, erectile dysfunction, menstrual irregularities
Interactions
- Potassium supplements, ACE inhibitors, ARBs, NSAIDs, heparin, trimethoprim: risk of severe hyperkalaemia
- Lithium: reduced clearance, monitor lithium levels
- NSAIDs may reduce the effect
Pregnancy and breastfeeding
- Because of potential effects on sex differentiation of a male fetus, avoid in pregnancy or advise of the risk
- The active metabolite canrenone appears in breast milk in low amounts
Summary of the official product information, written with AI on 2026-10-28. Every number was checked automatically against the original text. Not reviewed by a physician – the full official text is authoritative.
Common questions – ask Medelix
For patients
Patient information (US)
This product has no separate US patient information.
Authorisation and brand names by country
Medicines with exactly this active-substance composition, as listed in the national registers – alphabetical and without ranking. Whether a product is currently available is not shown here.
USA
- AldactonePfizer Laboratories Div Pfizer Inc · 1 register entry
Source: U.S. FDA – Drug labels (openFDA/DailyMed), as of 2026-10-28
Germany
- AldactoneEsteve Pharmaceuticals Gmbh · 1 register entry
- SpirobetaBetapharm Arzneimittel Gmbh · 1 register entry
- Spironolacton1 A Pharma Gmbh, Ratiopharm Gmbh, Heumann Pharma Gmbh & Co. Generica Kg, Accord Healthcare B.V., Aristo Pharma Gmbh (Art 57), Hexal Ag, Stadapharm Gmbh, Aliud Pharma Gmbh · 8 register entries
Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28
Austria
- AldactoneCheplapharm Arzneimittel Gmbh · 1 register entry
- SpirobeneTeva B.V · 1 register entry
- SpirohexalHexal Pharma Gmbh · 1 register entry
- SpironoGenericon Pharma Gesellschaft M.B.H. · 1 register entry
- Spironolacton AgephaAgepha Pharma S.R.O · 1 register entry
- Spironolacton OrionOrion Corporation · 1 register entry
- Spironolactone OrionOrion Corporation · 1 register entry
Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28
Turkey
- AldactoneALİ RAİF İLAÇ SAN. A.Ş. · 3 register entries
- DalylactonPHARMAPLACE İLAÇ TİC. A.Ş. · 3 register entries
- RidaktonGEN İLAÇ VE SAĞLIK ÜRÜNLERİ SAN. VE TİC. A.Ş. · 3 register entries
- SpylactonWORLD MEDICINE İLAÇ SAN. VE TİC. A.Ş. · 4 register entries
Source: TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, as of 2026-10-16
Brand names in 27 more European countries
- Belgium
- Aldactone, Spironolactone Eg
- Bulgaria
- Спилактон, Спиронолактон Акорд, Спиронолактон Актавис, Спиронолактон Медокеми, Спиронолактон Чайкафарма
- Croatia
- Aldactone
- Cyprus
- Spiro, Spirolon, Spironolactone Accord, Spironolactone Medochemie, Spironolactone Remedica, Uractonum
- Czechia
- Spironolactone Medreg, Spironolactone Orion, Verospiron
- Denmark
- Spirix, Spiron, Spironolactone Accord, Spironolactone Viatris
- Estonia
- Spirix, Spironolactone Accord, Spironolactone Medochemie
- Finland
- Spirix, Spironolactone Orion
- France
- Aldactone, Spironolactone Arrow, Spironolactone Cristers, Spironolactone Eg, Spironolactone Pfizer, Spironolactone Sandoz, Spironolactone Teva, Spironolactone Viatris, Spironolactone Zentiva, Spironolactone Zydus
- Greece
- Aldactone
- Hungary
- Spiron, Spironolactone Orion, Verospiron
- Iceland
- Spirix, Spiron
- Ireland
- Aldactone, Spironolactone Accord Healthcare Ireland
- Italy
- Aldactone, Spirolang, Uractone
- Latvia
- Spirix, Spironolactone Accord, Verospiron
- Lithuania
- Spirix, Spironolactone Accord, Spironolactone Medochemie, Spironolactone Orion
- Luxembourg
- Aldactone, Spironolacton Ratiopharm, Spironolactone Eg
- Malta
- Aldactone, Spirolon, Spironolactone Medochemie
- Netherlands
- Spironolacton Accord, Spironolacton Genrx, Spironolacton Mylan, Spironolacton Prolepha, Spironolactone Aurobindo
- Norway
- Spirix, Spironolactone Orion
- Poland
- Finospir, Spironol, Spironolactone Medreg, Verospiron
- Portugal
- Aldactone, Espironolactona Alter, Espironolactona Generis, Espironolactona Mylan
- Romania
- Alspiron, Spironolactonă Arena, Spironolactonă Bioeel, Spironolactonă Gemax Pharma, Spironolactonă Lph Labormed, Spironolactonă Terapia, Verospiron
- Slovakia
- Medospir, Spironolactone Accord, Spironolactone Medreg, Verospiron
- Slovenia
- Aldactone, Spironolakton Orion
- Spain
- Aldactone, Espironolactona Accord, Espironolactona Alter, Espironolactona Orion
- Sweden
- Spironolactone Accord, Spironolactone Orion, Spironolakton Orifarm, Spironolakton Pfizer
EMA – Article 57 product data (EU/EEA), 2026-10-28
Medelix receives no money from pharmaceutical companies. Brand names are listed alphabetically and without ranking.
Other substances in the same group
Another question about this substance?
Medelix answers clinical questions from guidelines, studies and product information – every claim with its source.
Sources
- U.S. Food and Drug Administration. Aldactone (Pfizer Laboratories Div Pfizer Inc) – Prescribing Information, 2025-11-28. DailyMed (NLM), 2026-10-27. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0fed2822-3a03-4b64-9857-c682fcd462bc
- U.S. FDA – Drug labels (openFDA/DailyMed), 2026-10-28. https://dailymed.nlm.nih.gov/dailymed/
- EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, 2026-10-16. https://www.titck.gov.tr/dinamikmodul/85
- Wikidata (CC0): ATC C03DA.
Editorial: Medelix editorial team · last updated 2026-10-27 · How these pages are made · Report an error
Source: U.S. Food and Drug Administration (FDA), prescribing information, via DailyMed (NLM); public domain. Not advertising, not a treatment recommendation. For questions about your own treatment, ask your doctor or pharmacist.